AngioDynamics Valuation

ANGO Stock  USD 12.07  0.22  1.79%   
What is the intrinsic value of AngioDynamics stock? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as AngioDynamics, is its stock price multiplied by the total number of shares outstanding, calculating AngioDynamics' enterprise value requires a different approach. It uses AngioDynamics' balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
As of 23rd of March 2023, Tangible Asset Value is likely to grow to about 193.4 M, while Free Cash Flow is likely to drop (21.2 M).
AngioDynamics shows a prevailing Real Value of $16.45 per share. The current price of the firm is $12.07. At this time, the firm appears to be undervalued. Our model approximates the value of AngioDynamics from analyzing the firm fundamentals such as profit margin of (0.1) %, and Return On Equity of (0.08) % as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor obtaining undervalued instruments and abandoning overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
AngioDynamics Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as AngioDynamics's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.

AngioDynamics Most Recent Valuation Data

Change Receivables
-17.2 M
Fiscal Year End
Property Plant And Equipment Net
45 M
Enterprise Value
516.8 M
Today 12.07
Please note that AngioDynamics' price fluctuation is not too volatile at this time. Calculation of the real value of AngioDynamics is based on 3 months time horizon. Increasing AngioDynamics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for AngioDynamics is useful when determining the fair value of the AngioDynamics stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of AngioDynamics. Since AngioDynamics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of AngioDynamics Stock. However, AngioDynamics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Real Value
Estimating the potential upside or downside of AngioDynamics helps investors to forecast how AngioDynamics stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of AngioDynamics more accurately as focusing exclusively on AngioDynamics' fundamentals will not take into account other important factors:
LowEstimated ValueHigh
3 Analysts
LowTarget PriceHigh
Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use AngioDynamics' intrinsic value based on its ongoing forecasts of AngioDynamics' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against AngioDynamics' closest peers. When choosing an evaluation method for AngioDynamics, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.

AngioDynamics Investments

1.22 Million

AngioDynamics Valuation Drivers Correlation

Many accounts on the financial statements of AngioDynamics are highly interrelated and sometimes correlated. Consequently, when conducting AngioDynamics's valuation analysis, one should examine all of the accounts reported to obtain a complete picture of its financial situation. We provide a unique feature to present a conventional correlation table purposely composed against different valuation-related drivers of AngioDynamics
Click cells to compare fundamentals

AngioDynamics Valuation Trend

Knowing AngioDynamics' actual value is paramount for traders to make sound investment determinations. AngioDynamics' real value is not only important for the investor to make better decisions but also for a more accurate overall view of AngioDynamics' financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both AngioDynamics' enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.

AngioDynamics Market Cap

AngioDynamics is number one stock in market capitalization category among related companies. Market capitalization of Health Care industry is presently estimated at about 12.55 Billion. AngioDynamics holds roughly 487.22 Million in market capitalization claiming about 4% of equities under Health Care industry.
Capitalization  Total debt  Workforce  Revenue  Valuation

AngioDynamics Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining AngioDynamics's current stock value. Our valuation model uses many indicators to compare AngioDynamics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AngioDynamics competition to find correlations between indicators driving AngioDynamics's intrinsic value. More Info.
AngioDynamics is number one stock in price to book category among related companies. It is number one stock in price to sales category among related companies fabricating about  1.24  of Price to Sales per Price to Book. As of 23rd of March 2023, Price to Sales Ratio is likely to drop to 2.59. Comparative valuation analysis is a catch-all model that can be used if you cannot value AngioDynamics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for AngioDynamics' Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the AngioDynamics' earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates AngioDynamics' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in AngioDynamics and how it compares across the competition.

About AngioDynamics Valuation

The stock valuation mechanism determines the current worth of AngioDynamics on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of AngioDynamics. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of AngioDynamics based exclusively on its fundamental and basic technical indicators. By analyzing AngioDynamics's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of AngioDynamics's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of AngioDynamics. We calculate exposure to AngioDynamics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to AngioDynamics's related companies.
Fiscal Year End
Medical Instruments & Supplies
Health Care Equipment
Full Time Employees
Service Category
Health Care Equipment & Supplies
Last ReportedProjected for 2023
Gross Profit149.2 M145.1 M
Profit Margin(0.08) (0.08) 

AngioDynamics Quarterly Enterprise Value

531.68 Million

8 Steps to conduct AngioDynamics' Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates AngioDynamics' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct AngioDynamics' valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain AngioDynamics' financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine AngioDynamics' revenue streams: Identify AngioDynamics' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research AngioDynamics' industry and market trends, including the size of the market, growth rate, and competition.
  • Establish AngioDynamics' growth potential: Evaluate AngioDynamics' management, business model, and growth potential.
  • Determine AngioDynamics' financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate AngioDynamics' estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

AngioDynamics Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as AngioDynamics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding39 M
Forward Price Earnings1111.1111
Retained Earnings-158.4 M
Retained Earnings Total Equity-158.4 M

AngioDynamics Current Valuation Indicators

Valuation refers to the process of determining the present value of AngioDynamics and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value AngioDynamics we look at many different elements of the entity such as AngioDynamics's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. AngioDynamics' valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final AngioDynamics' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as AngioDynamics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use AngioDynamics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes AngioDynamics' worth.
Check out Trending Equities. To learn how to invest in AngioDynamics Stock please use our How to Invest in AngioDynamics guide. Note that the AngioDynamics information on this page should be used as a complementary analysis to other AngioDynamics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Complementary Tools for AngioDynamics Stock analysis

When running AngioDynamics price analysis, check to measure AngioDynamics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AngioDynamics is operating at the current time. Most of AngioDynamics' value examination focuses on studying past and present price action to predict the probability of AngioDynamics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move AngioDynamics' price. Additionally, you may evaluate how the addition of AngioDynamics to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Fundamental Analysis
View fundamental data based on most recent published financial statements
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Is AngioDynamics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
Revenue Per Share
Quarterly Revenue Growth
Return On Assets
Return On Equity
The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine AngioDynamics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.